FEB 26, 2020 7:01 PM PST

Immunotherapy Could Be Used to Treat Traumatic Brain Injury

WRITTEN BY: Amanda Mikyska

Video:  Further explaination of microglia and their various functions. 

Traumatic Brain Injuries are physical injuries to the brain which cause inflammation and are known to cause neurodegenerative diseases like Alzheimer’s, Dementia, and Chronic Traumatic Encephalopathy (CTE), which has been in sports headlines regarding concussions.  Researchers at Trinity College in Dublin and the University of Maryland School of Medicine are working on a possible immunotherapy to reduce inflammation after a TBI and reduce risk of neurodegenerative diseases.  

When a person experiences a TBI, for example a concussion, microglia cells become inflamed and effectively form a protective cushion around the brain.  Microglia are the brain’s immune cells, but long periods of inflammation, or many cycles of inflammation, cause neurological and cognitive damage.  

The researchers have now shown that inhibiting a gene in the microglia, necessary for their survival, will decrease inflammation and reduce risk of developing a neurodegenerative disease.  The researchers controlled a TBI in mice, then one month after the injury, they inhibited the CSF1R receptor in microglia cells. One week after inhibition, the receptor was controlled to resume normal activity.  The researchers found that turning off the critical receptor killed 95% of microglia cells, which dramatically decreased inflammation. Furthermore, when the receptors were allowed to resume activity, they were “reset” to normal activity, not a highly inflamed state.  

Though this is an early study in mice, researchers from a variety of backgrounds are interested in testing the concept with more specific parameters. 

 

Sources: Henry, et. al., PubMed, NeuroscienceNews

About the Author
  • Amanda graduated for the University of Massachusetts Boston with a degree in Biology. After working in research on creating biochemicals from genetically engineered yeast, she started freelance science writing while traveling the world. She writes about the latest research in Neuroscience, Genetics & Genomics, and Immunology. Interested in working on solutions for food/water security, sustainable fuel, and sustainable farming. Amanda is an avid skier, podcast listener, and has run two triathlons.
You May Also Like
DEC 20, 2019
Neuroscience
DEC 20, 2019
Does Having Herpes Increase Your Risk for Alzheimer's?
Around 44 million people around the world have Alzheimer’s disease, a progressive form of dementia that leads to memory loss and a decline in cogniti...
FEB 17, 2020
Neuroscience
FEB 17, 2020
Being Bilingual Accelerates Alzheimer's Disease in the Brain
Although knowing two languages may be able to delay the onset of Alzheimer’s, researchers from Canada’s York University have found that it may ...
MAR 01, 2020
Genetics & Genomics
MAR 01, 2020
Treating Huntington's Disease With a Gene Therapy That Targets Brain Cells
A new therapeutic approach for Huntington's disease may aid patients with other neurodegenerative disorders....
MAR 13, 2020
Technology
MAR 13, 2020
Advancing Brain-Machine Interfaces
At Stanford University, researchers have designed a device that connects the brain to silicon-based technologies. Although the brain-machine interface devi...
MAR 31, 2020
Neuroscience
MAR 31, 2020
How Stress Restructures the Brain
Stress doesn’t only exacerbate our physiology- from our cardiovascular system to our immune system and digestive system. Now, new research has found ...
APR 03, 2020
Neuroscience
APR 03, 2020
Why Autism is More Common in Boys than Girls
Researchers from the National Institutes of Health (NIH) have identified how a change in a single amino acid may be linked to symptoms of autism. In partic...
Loading Comments...